Correlation Between Nanoform Finland and Isofol Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nanoform Finland and Isofol Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanoform Finland and Isofol Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanoform Finland Plc and Isofol Medical AB, you can compare the effects of market volatilities on Nanoform Finland and Isofol Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanoform Finland with a short position of Isofol Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanoform Finland and Isofol Medical.

Diversification Opportunities for Nanoform Finland and Isofol Medical

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nanoform and Isofol is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Nanoform Finland Plc and Isofol Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isofol Medical AB and Nanoform Finland is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanoform Finland Plc are associated (or correlated) with Isofol Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isofol Medical AB has no effect on the direction of Nanoform Finland i.e., Nanoform Finland and Isofol Medical go up and down completely randomly.

Pair Corralation between Nanoform Finland and Isofol Medical

Assuming the 90 days trading horizon Nanoform Finland Plc is expected to generate 1.39 times more return on investment than Isofol Medical. However, Nanoform Finland is 1.39 times more volatile than Isofol Medical AB. It trades about 0.09 of its potential returns per unit of risk. Isofol Medical AB is currently generating about -0.22 per unit of risk. If you would invest  1,562  in Nanoform Finland Plc on September 1, 2024 and sell it today you would earn a total of  138.00  from holding Nanoform Finland Plc or generate 8.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Nanoform Finland Plc  vs.  Isofol Medical AB

 Performance 
       Timeline  
Nanoform Finland Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nanoform Finland Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Isofol Medical AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Isofol Medical AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Isofol Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Nanoform Finland and Isofol Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nanoform Finland and Isofol Medical

The main advantage of trading using opposite Nanoform Finland and Isofol Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanoform Finland position performs unexpectedly, Isofol Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isofol Medical will offset losses from the drop in Isofol Medical's long position.
The idea behind Nanoform Finland Plc and Isofol Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments